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Mammalian cells rely on cellular uptake of the essential amino acid tryptophan. Tryptophan sequestration by up-
regulation of the key enzyme for tryptophan degradation, indoleamine 2,3-dioxygenase (IDO), e.g., in cancer and
inflammation, is thought to suppress the immune response via T cell starvation. Additionally, the excreted tryptophan
catabolites (kynurenines) induce apoptosis of lymphocytes. Whereas tryptophan transport systems have been
identified, the molecular nature of kynurenine export remains unknown. To measure cytosolic tryptophan steady-state
levels and flux in real time, we developed genetically encoded fluorescence resonance energy transfer nanosensors
(FLIPW). The transport properties detected by FLIPW in KB cells, a human oral cancer cell line, and COS-7 cells implicate
LAT1, a transporter that is present in proliferative tissues like cancer, in tryptophan uptake. Importantly, we found that
this transport system mediates tryptophan/kynurenine exchange. The tryptophan influx/kynurenine efflux cycle
couples tryptophan starvation to elevation of kynurenine serum levels, providing a two-pronged induction of
apoptosis in neighboring cells. The strict coupling protects cells that overproduce IDO from kynurenine accumulation.
Consequently, this mechanism may contribute to immunosuppression involved in autoimmunity and tumor immune
escape.
Citation: Kaper T, Looger LL, Takanaga H, Platten M, Steinman L, et al. (2007) Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle. PLoS
Biol 5(10): e257. doi:10.1371/journal.pbio.0050257
Introduction
L-tryptophan is an essential amino acid necessary for
protein synthesis in mammalian cells. Moreover, tryptophan
is the precursor for the neurotransmitter serotonin, for the
hormone melatonin, and contributes to the synthesis of the
coenzymes NADH and NADPH. Degradation products of
tryptophan have immunoregulatory functions. Mammalian
cells cannot synthesize L-tryptophan, and thus depend on
transport machineries for its uptake and protein turnover for
its production. Because cell growth is strictly dependent on
tryptophan serum levels, different cell types compete for this
amino acid, for instance in the regulation of the immune
response. Identiﬁed transporter proteins potentially involved
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amino acid exchangers; they countertransport cytosolic
amino acids for extracellular ones. LAT1 is present in
proliferative tissues and, as such, is up-regulated in many
human primary tumor cells [10].
Tryptophan can be degraded through the kynurenine
pathway, e.g., for the biosynthesis of vitamin B3 or niacin,
which is needed for the synthesis of coenzyme NADH or
NADPH. The rate-limiting step in this pathway is the opening
of the indole ring by indoleamine 2,3-dioxygenase (IDO).
Since the discovery that inhibition of IDO induced fetal
allograft rejection in mice, the immunosuppressive function
of tryptophan catabolism has been well established [11]. One
proposed mechanism for the observed immunosuppression is
the local depletion of tryptophan, which inhibits adaptive T
cell responses by forcing them into growth arrest and
inducing apoptosis [12]. As such, the immune escape of many
cancer cell types correlates with up-regulated IDO expression
and can, in some cases, be overcome by IDO inhibition
[13,14]. In addition, products of the kynurenine pathway are
immunosuppressive and may provide leads for the treatment
of autoimmune disorders such as multiple sclerosis [15].
Kynurenines are natural amino acids found in mammals;
however, the transport machinery for their export across the
cell membrane is not known.
Traditionally, cellular uptake of molecules has been
determined using radiolabeled substrates, and cellular levels
have been measured in extracts via liquid chromatography or
gas chromatography/mass spectrometry. Both methods are
neither time resolved nor speciﬁc, and they lack high
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PLoS BIOLOGYtemporal or cellular/subcellular resolution. Tryptophan is
aromatic, binding nonspeciﬁcally to many molecules. Given
t h ei m p o r t a n c eo fL-tryptophan for human health, an
analytical tool for noninvasive, time-resolved determination
of intracellular L-tryptophan levels was deemed desirable.
Fluorescent indicator proteins (FLIPs) are new tools for
real-time monitoring of metabolite levels and have been used
successfully for monitoring several small molecules in
subcompartments in living cells. Typically, the nanosensors
consist of a ligand-sensing domain, allosterically coupled to a
pair of green ﬂuorescent protein variants capable of
ﬂuorescence resonance energy transfer (FRET). FRET re-
quires donor and acceptor ﬂuorophores with overlapping
emission and excitation spectra, respectively. After excitation
of the donor, energy is transmitted to the acceptor in a
nonradiative manner and emitted by the acceptor. The
efﬁciency of this process depends on the distance between
and relative orientation of the dipoles of the ﬂuorophores.
Ligand binding–induced conformational changes in the
sensors result in altered FRET efﬁciencies, which correlate
with the levels of the respective metabolites. Periplasmic
binding proteins (PBPs) have been successfully exploited for
the construction of FLIPs for imaging of key metabolites such
as glucose [16], maltose [17], ribose [18], and glutamate [19].
However, no tryptophan-binding PBPs have been described
to date; thus an alternative ligand-sensing scaffold was
explored for construction of a tryptophan nanosensor.
In c-proteobacteria like Escherichia coli, transcription of the
tryptophan biosynthetic operon is regulated by attenuation
[20] and by the inhibitory binding of the tryptophan-
activated repressor protein, TrpR, to the trp operator [21].
Binding of L-tryptophan to the repressor results in conforma-
tional changes that enhance the repressor’s afﬁnity for the
operator sequence [22]. We have exploited the ligand-
induced conformational changes of TrpR for the construc-
tion of novel genetically encoded sensors for monitoring of in
vivo L-tryptophan levels. First, we demonstrate the applic-
ability of the metabolite FRET nanosensor technology to
novel ligand-sensing domains and instigate new methods for
the construction of nanosensors for metabolites that are only
present inside the cell (and therefore are unlikely to be
recognized by evolved PBPs). Second, we use a novel strategy
for the optimization of the FRET signal based on the
particular topology and conformation of TrpR. Third, we
express the optimized FRET tryptophan sensor in KB and in
COS-7 cells and ﬁnd that these cells take up tryptophan by a
LAT amino acid exchanger. Finally, we demonstrate that this
transporter mediates tryptophan/kynurenine exchange,
which, in cooperation with IDO, provides a new metabolic
cycle that may contribute to the immune escape of various
tumor cells as well as a favorable role of kynurenines in
reducing autoimmunity, while at the same time protecting
the cells that overproduce IDO from kynurenine accumu-
lation.
Results
A Ligand-Binding Scaffold for L-Tryptophan
The E. coli tryptophan operon repressor TrpR is an all-
helical polypeptide of 108 amino acids organized into 6 a
helices. This polypeptide forms a dimer that selectively binds
two molecules of L-tryptophan with micromolar afﬁnity
(Figure 1A) [23]. In the active, dimeric conformation of
TrpR, ﬁve of the six helices in each polypeptide are involved
in intermolecular contacts [24]. With both chains contribu-
ting to each tryptophan-binding site, two TrpR polypeptides
are necessary to form the two functional intermolecular
binding sites (Figure 1A). In the absence of tryptophan, a part
of TrpR is unfolded [25], which likely corresponds to the
Figure 1. Tryptophan Sensors Based on the E. coli Tryptophan Repressor
TrpR
(A) TrpR dimer (yellow, red) in complex with L-tryptophan (black) bound
to the trp operator (green, blue) ([28]). (B) FLIPW variants. (C) Normalized
FRET ratio change of FLIPW-CTY (red squares), FLIPW-TCTY (cyan circles),
FLIPW-CTYT (green triangles), and FLIPW-CTTY (yellow squares) in the
presence of L-tryptophan. (D) Normalized FRET ratio change of FLIPW-
CTYT in presence of L-tryptophan (red squares), D-tryptophan (cyan
circles), 5-hydroxy-L-tryptophan (yellow squares), and 5-methyl-L-trypto-
phan (green triangles). Inset in (D) highlights the response of FLIPW-CTYT
to tryptophan in the low micromolar range. Ratio is defined as
fluorescence intensity quotient of emission at 528 nm/485 nm.
doi:10.1371/journal.pbio.0050257.g001
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Author Summary
Although regulated suppression of the immune system prevents
autoimmunity and is important during pregnancy to protect the
fetus or after organ transplant to block graft rejection, it can be
harmful if co-opted by tumors to escape detection. T cells of the
immune system normally recognize and destroy abnormal cells,
including cancerous and grafted tissues. This process requires the
amino acid tryptophan. Foreign grafts and cancer cells can dampen
the immune response by starving T cells of tryptophan through a
mechanism involving uptake and conversion to kynurenines using
an enzyme called indoleamine-2,3-dioxygenase (IDO). Independent
of tryptophan starvation, kynurenines induce T cell death when they
are excreted through an unknown mechanism. We constructed
fluorescent nanosensors that report tryptophan levels in two
immortalized cell lines, COS-7 cells and human oral cancer KB cells.
Using single-cell, real-time imaging analysis, we demonstrate that an
L-amino acid transporter protein (LAT1) exchanges tryptophan for
its kynurenine degradation products. LAT1 together with IDO forms
a metabolic minicycle that couples tryptophan starvation with
kynurenine-induced cell death, providing a two-pronged inactiva-
tion of neighboring cells. The strict coupling protects the cells that
overproduce IDO from accumulating kynurenine. This cycle may
contribute to suppression of the immune response in autoimmune
diseases and cancer.helix-turn-helix motifs that form the DNA-reading heads.
Crystallographic analysis shows that the helix-turn-helix
motif undergoes structural rearrangements upon binding of
tryptophan [22], and the motif’s ﬂexibility is essential for the
recognition of operator sequences [26]. In addition, trypto-
phan binding results in a shift of the relative distance and
orientation of the N and C termini of each repressor
polypeptide with respect to one another [22], which we
detected as a change in FRET when TrpR was fused to a FRET
ﬂuorophore pair. The E. coli tryptophan repressor gene was
sandwiched between enhanced cyan ﬂuorescent protein
(eCFP) and Venus (a yellow ﬂuorescent protein variant)
coding sequences (Figure 1B). Production of the translated
fusion product FLIPW-CTY (CTY: eCFP-TrpR-VenusYFP) in
E. coli was readily detected by recording the emission
spectrum of the eCFP-Venus FRET signal in cell cultures.
When eCFP was excited, signiﬁcant energy transfer to Venus
was detected, resulting in a Venus/eCFP ratio of 4 (Table S1).
Addition of L-tryptophan decreased FRET efﬁciency of the
puriﬁed protein, visible as an increase in eCFP emission
intensity and a concomitant decrease in Venus ﬂuorescence
intensity, resulting in a 10% reduction in the Venus/eCFP
ratio (Figure 1C). FLIPW-CTY bound L-tryptophan with an
apparent dissociation constant (Kd) of 220 6 20 lM, which is
about one order of magnitude higher compared with
unmodiﬁed TrpR as measured by equilibrium dialysis [23].
Small molecules are known to quench ﬂuorophore emission
efﬁciently due to nonspeciﬁc interactions [27]. To exclude
that the negative ratio change observed for FLIP-CTY is due
to unspeciﬁc effects, the FRET response was measured in the
presence of D-tryptophan. Compared with L-tryptophan,
unmodiﬁed TrpR has a 20-fold reduced afﬁnity for D-
tryptophan [23]. Titration of FLIPW-CTY with D-tryptophan
resulted in a decrease of the FRET ratio at about 5-fold
higher concentrations than L-tryptophan (Figure S1). Because
D- and L-tryptophan would be expected to have the same
quenching properties, this strongly suggests that the decrease
in FRET ratio of FLIPW-CTY is due to a speciﬁc interaction
of the sensor with tryptophan.
Twin-Cassette FLIPW Nanosensor Variants
The active conformation of TrpR is a dimer, and two
tryptophan-binding sites are formed at the dimer interface
[28]. Therefore, one assumes that the functional FLIPW-CTY
sensor functions as a dimer of two CTY polypeptides, with the
four ﬂuorophores being packed tightly together, potentially
affecting the binding afﬁnity due to steric hindrance or
resulting in signal loss due to averaging of the ﬂuorophore
signals. Thus fusing two TrpR molecules to one ﬂuorophore
set may give rise to sensors with a single eCFP-Venus pair per
sensor, which may have improved sensing characteristics.
Three sensor permutations containing two TrpR copies (a
and b) in a single gene product were constructed (Figure 1B).
In the permutants FLIPW-TCTY (linear arrangement of
TrpR
a-eCFP-TrpR
b-Venus) and FLIPW-CTYT (linear ar-
rangement of eCFP-TrpR
a-Venus-TrpR
b) the distance be-
tween the N and C termini of the intercalated green
ﬂuorescent protein variants (eCFP in TCTY and Venus in
CTYT) corresponds well to the distance between the C
terminus of the ﬁrst TrpR polypeptide (a) and the N terminus
of the second TrpR (b) in the dimer (;22 A ˚ , Figure S2). One
of the ﬂuorophores in these variants is therefore rotationally
constrained by these attachment points, a fact that is
expected to lead to an improvement of the signal change
due to decreased conformational averaging as shown for
other ‘‘insertional’’ FRET sensors [29,30]. The third variant,
FLIPW-CTTY, is a linear fusion in the order eCFP-TrpR
a-
TrpR
b-Venus. For the construction of FLIPW-CTTY, two
copies of the repressor gene were connected by a ﬂexible
linker consisting of seven glycine residues and inserted
between the ﬂuorophores. This linker was designed to loosely
connect the two TrpR proteins without changing the dimer
conformation, and is based on a model constructed in
Modeller8v1 [31]. Whereas the FRET ratio of FLIPW-CTTY
and FLIPW-TCTY changed only slightly when titrated with L-
tryptophan, FLIPW-CTYT yielded a substantially improved
tryptophan sensor (Figure 1C and 1D). The apparent binding
constant of FLIPW-TCTY for L-tryptophan was ;20 lM,
comparable to unmodiﬁed TrpR [23]. The ratio change
observed for FLIPW-CTTY could not be ﬁtted to a single-site-
binding isotherm (see Material and Methods).
When FLIPW-CTYT was titrated with L-tryptophan, an
increase in FRET ratio from 2.2 to 2.8 was observed,
indicating a signiﬁcant change in chromophore orientation
with respect to FLIPW-CTY. The ratio change observed in
vitro for FLIPW-CTYT was þ35%. FLIPW-CTYT bound L-
tryptophan with an apparent afﬁnity of 100 6 10 lM.
Analogous to the wild-type TrpR, FLIPW-CTYT binds ligands
in order of decreasing afﬁnity: L-5-methyl-tryptophan . L-
tryptophan . D-tryptophan . L-5-hydroxy-tryptophan (Table
S2) [23]. The positive ratio change permits efﬁcient discrim-
ination of quenching effects; thus, FLIPW-CTYT appears
better suited for in vivo measurements compared to FLIPW-
CTY, which shows a negative ratio change (Table S1).
Therefore FLIPW-CTYT was chosen to monitor physiological
tryptophan levels in mammalian cells (dynamic range ; 15
lM to 1 mM).
Molecular Modeling of FLIPW Sensors
Molecular modeling was performed to rationalize the
observed FRET signal changes. The original sensor, FLIPW-
CTY, is predicted to dimerize, resulting in an antiparallel
arrangement of the TrpR polypeptides, thus resulting in two
sets of eCFP and Venus ﬂuorophores in close vicinity at both
sides of the TrpR dimer (Figure 2A). In agreement with the
close vicinity of the ﬂuorophores, FLIPW-CTY showed the
highest FRET efﬁciency (Table S1). The FLIPW-CTYT sensor
is modeled to form a functional TrpR dimer intramolecularly,
resulting in a single eCFP and a single Venus molecule per
sensor (Figure 2B). FLIPW-CTYT has lower absolute energy
transfer efﬁciency, which is consistent with the greater
distance between the ﬂuorophore dipoles. The relative FRET
change is higher compared to FLIPW-CTY, probably because
of the rigidiﬁcation of the attachment of the Venus molecule
by its fusion to both TrpR monomers. The FLIPW-CTTY and
FLIPW-TCTY sensors do not show sufﬁcient ligand-depend-
ent ratio changes to be useful as sensors. Molecular modeling
may explain the different responses of the FLIPW-CTYT and
FLIPW-TCTY sensors. In FLIPW-CTYT, a ﬂuorophore is
attached to the N terminus of TrpR
a, leading to a different
spatial arrangement and rotational probability space com-
pared to FLIPW-TCTY, in which Venus is attached to the C
terminus of TrpR
b. This geometrical difference is presumably
PLoS Biology | www.plosbiology.org October 2007 | Volume 5 | Issue 10 | e257 2203
Monitoring of Tryptophan–Kynurenine Exchangetransduced into altered dipole orientations in the FLIPW-
CTYT sensor (Figure S3).
Tryptophan Uptake in COS-7 Cell Cultures in 96-Well
Microplates
To measure tryptophan ﬂux in the cytosol of live cells,
COS-7 cell cultures seeded in a 96-well microplate were
transiently transfected with pTK222 for cytosolic production
of FLIPW-CTYT sensor. Microscopic analysis of transfected
cells showed that FLIPW-CTYT was produced in the cytosol.
When microwell-grown cells expressing FLIPW-CTYT were
incubated in Tyrode’s buffer containing tryptophan and
analyzed in a microplate reader, an increase in FRET ratio
was observed, indicating an increase in cytosolic tryptophan
levels as a result of uptake (Figure 3A). The rate in FRET
increase depended on the external tryptophan concentration
and showed Michaelis-Menten type kinetics with an apparent
afﬁnity constant KM of 0.88 6 0.27 lM for combined
transport and metabolism (Figure 3B). The FLIPW-CTYT
sensor thus appears suitable to study factors inﬂuencing
tryptophan transport and metabolism and can be used in
high-throughput ﬂuorescence-based assays and drug screens.
Tryptophan Uptake and Exchange in COS-7 Cells Is
Mediated by a LAT1-Like Amino Acid Exchanger
Reported intracellular tryptophan levels in mammalian
cells cultivated in batch are in the 0.27–0.60 mM range [32];
thus, they are compatible with the detection range of the
FLIPW-CTYT sensor. When COS-7 cells producing cytosolic
FLIPW-CTYT sensor were perfused with Tyrode’s buffer, the
initial FRET ratio (528 nm/485 nm [Venus/eCFP] emission
intensity) was stable (Figure 4A). Upon perfusion with 100 lM
L-tryptophan, the FRET ratio increased instantaneously,
corresponding to rising levels of cytosolic tryptophan. The
FRET ratio was stable during subsequent perfusion with
buffer, indicating that the cytosolic steady-state tryptophan
levels remain constant and that in COS-7 cells tryptophan
uniporters like TAT1 [3] do not contribute signiﬁcantly to
transport. When L-histidine was provided in the medium, the
eCFP emission increased and Venus emission decreased,
evidencing a decrease in FRET efﬁciency as a result of export
of tryptophan from the cytosol. This way, cells could be
repeatedly loaded with tryptophan and unloaded using
Figure 2. Structural Models of FLIPW-CTY and FLIPW-CTYT Tryptophan
Sensors
TrpR: green, magenta, eCFP: blue, and Venus: yellow. (A) Dimer of two
FLIPW-CTY chains resulting in a TrpR dimer that can bind tryptophan. (B)
FLIPW-CTYT monomer. The relative positions of the fluorophore proteins
with respect to the TrpR dimer are speculative.
doi:10.1371/journal.pbio.0050257.g002
Figure 3. Uptake of Tryptophan by COS-7 Cell Cultures in 96-Well
Microplates Monitored with FLIPW-CTYT
(A) FRET ratio change of cell cultures in presence of Tyrode’s buffer
(squares) and 100 lM L-tryptophan in Tyrode’s buffer (circles). Data
correspond to means 6 SE (n ¼ 12). (B) Velocity of intracellular FLIPW-
CTYT response versus external tryptophan concentration fitted with the
Michaelis-Menten equation. Cells were incubated with 0.05, 0.1, 0.25, 0.5,
1, 5, 10, and 25 lM L- tryptophan. Data correspond to means 6 SE (n ¼
6). Ratios are defined as fluorescence intensity quotient of emission at
528 nm/485 nm.
doi:10.1371/journal.pbio.0050257.g003
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Monitoring of Tryptophan–Kynurenine Exchangehistidine (Figure 4A). By comparison of the starting, mini-
mum, and maximum response levels of the sensor, assuming
that the Kd of the sensor expressed in cells was the same as in
vitro, the cytosolic tryptophan concentration was estimated
at 340 lM. The afﬁnity of the cells for combined uptake and
metabolism of tryptophan was 2.6 6 1.1 lM (Figure 4B). The
system L inhibitor 2-aminobicyclo-(2,2,1)-heptane-2-carbox-
ylic acid (BCH) decreased the uptake of tryptophan, whereas
either replacement of sodium with choline or the transport
system A inhibitor N-(methylamino)isobutyric acid did not
decrease uptake rates (Figure 4C). Na
þ independence and
BCH sensitivity are characteristic of the transport properties
of LAT1- and LAT2-like amino acid counterexchangers [6].
Similar to histidine, the larger hydrophobic and aromatic
amino acids leucine, isoleucine, valine, methionine, phenyl-
alanine, and tyrosine were able to promote tryptophan
export (at 100 lM concentrations, unpublished data), an
observation that corresponds best to the reported substrate
speciﬁcity of LAT1 [33–35]. LAT2 is expressed in the
proximal tubule of the kidney [6], so it might be expressed
in COS-7 cells. In addition, LAT1 is expressed in various
human tumor cell lines [35] and, consequently, is likely to be
present in COS-7 cells as well.
Tryptophan Is Exchanged for Its Kynurenine Degradation
Products
The product of tryptophan conversion by IDO is for-
mylkynurenine (FK), which is, in turn, converted by the
enzyme kynurenine formamidase to kynurenine (K) (Figure
5A). The consecutive action of kynurenine-3-hydroxylase
produces 3-hydroxy-kynurenine (HK), which is further
degraded by kynureninase to hydroxy-anthranilic acid
(HAA) (Figure 5A). In vitro, K, HK, and HAA did not result
in a FLIPW-CTYT FRET response or interfere with trypto-
phan binding to the sensor (unpublished data). We tested the
Figure 5. Imaging of Tryptophan-Kynurenine Exchange with FLIPW-CTYT in COS-7 Cells
(A) Molecular structures of L-tryptophan, 3-hydroxy-L-kynurenine, and 3-hydroxy-anthranilic acid. (B) Perfusion of COS-7 cells with 100 lM L-tryptophan
(L-Trp), 100 lM L-histidine (L-His), and 200–1,000 lM 3-hydroxy-DL-kynurenine (DL-HK) in Tyrode’s buffer. According to the FRET theory, an increase in
Venus signal is accompanied by a decrease in eCFP signal. Ratio defined as fluorescence intensity quotient obtained with emission filters 535/40 nm
over 480/30 nm.
doi:10.1371/journal.pbio.0050257.g005
Figure 4. Imaging of Intracellular Tryptophan Levels with FLIPW-CTYT in COS-7 Cells
(A) Perfusion of COS-7 cells with various concentrations L-tryptophan (L-Trp) and 100 lM L-histidine (L-His) in Tyrode’s buffer. According to the FRET
theory, an increase in Venus signal is accompanied by a decrease in eCFP signal. Ratio defined as fluorescence intensity quotient obtained with emission
filters 535/40 nm over 480/30 nm. (B) Velocity of intracellular FLIPW-CTYT response versus external tryptophan concentrations used in (A) fitted with the
Michaelis-Menten equation. Error bars indicate standard deviation. (C) Effect of Na
þ-ions and inhibitors on the uptake rate of 100 lM L-tryptophan. Error
bars indicate standard deviation.
doi:10.1371/journal.pbio.0050257.g004
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tryptophan levels in tryptophan-preloaded COS-7 cells. Both
extracellular K and HK resulted in a reduction of the
ﬂuorophore emission ratios in the COS-7 cells, evidencing
tryptophan export. The sensor responses for the K- and HK-
induced tryptophan were similar (unpublished data), and HK-
induced export is shown in Figure 5B. Extracellular HAA did
not result in tryptophan export (unpublished data). Thus, the
ﬁndings are compatible with the role of LAT-like trans-
porters that are present in COS-7 cells as exchangers of
tryptophan for its degradation products K and HK. Trypto-
phan, K, and HK thus appear to be substrates for LAT1 and
one may speculate that FK is a substrate as well. Since the
substrate speciﬁcities of LAT1 and LAT2 differ only in the
transport of small amino acids [33,36], we hypothesize that
both are capable of tryptophan-kynurenine exchange.
LAT1 Mediates Tryptophan-Kynurenine Exchange in
Human KB Cells
KB cells originate from a human oral squamous cell
carcinoma and express only LAT1 for uptake of neutral
amino acids as shown by reverse-transcriptase (RT)-PCR [37]
and RNA interference (RNAi) [38]. When KB cells expressing
FLIPW-CTYT were perfused with tryptophan, the FRET ratio
increased (Figure 6A). The FRET ratio did not change upon
subsequent perfusion with buffer, but it decreased upon
perfusion with histidine, conﬁrming amino acid exchange.
LAT1-mediated uptake and exchange of tryptophan was
Figure 6. Imaging of Tryptophan Uptake and Exchange with FLIPW-CTYT in Human Oral Carcinoma KB Cells
(A) Perfusion of KB cells with various concentrations L-tryptophan (L-Trp) and 100 lM L-histidine (L-His) in Tyrode’s buffer. According to the FRET theory,
an increase in Venus signal is accompanied by a decrease in eCFP signal. Ratio defined as fluorescence intensity quotient obtained with emission filters
535/40 nm over 480/30 nm. (B) Effect of 5 mM BCH inhibitor on the uptake rate of 100 lM L-tryptophan. Error bars indicate standard deviation. (C)
Velocity of intracellular FLIPW-CTYT response versus external tryptophan concentrations used in (A) fitted with the Michaelis-Menten equation. Error
bars indicate standard deviation. (D–F) Perfusion of KB cells with 100 lM L-tryptophan (L-Trp), 100 lM L-histidine (L-His), and 200 lM DL-kynurenine (DL-
K) (D), 200 lM 3-hydroxy-DL-kynurenine (DL-HK) (E), and 1,000 lM 3-hydroxy-anthranilic acid (HAA) (F) in Tyrode’s buffer. Cell images in panels (A) and
(D–F) are pseudocolored to demonstrate the ratio change.
doi:10.1371/journal.pbio.0050257.g006
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7 cells (Figure 6A) and was almost completely inhibited by
BCH (Figure 6B.). The afﬁnity of KB cells for combined
tryptophan uptake and metabolism under perfusion con-
ditions is 5.1 6 1.0 lM (Figure 6C), which is 2-fold lower than
that observed for the LAT1-like exchanger of COS-7 cells. In
addition, intracellular tryptophan was exported upon perfu-
sion with kynurenine (Figure 6D), 3-hydroxy-kynurenine
(Figure 6E), but not 3-hydroxy-anthranilic acid (Figure 6F),
indicating that human LAT1 mediates the exchange of
tryptophan for its kynurenine degradation products.
Discussion
Mammalian cells cannot synthesize the amino acid trypto-
phan and rely on its import as tryptophan or as components
of nutrients such as peptides across the plasma membrane for
basic cell functioning. Tryptophan is necessary for protein
synthesis, and it accounts for ;1.3 % of the amino acids in
human proteins. Tryptophan is also the precursor of other
vital molecules like serotonin, melatonin, and NAD. More-
over, kynurenines produced from tryptophan appear to play
a pivotal role in immunosuppression in inﬂammatory
diseases and cancer [39,40].
The FLIPW nanosensors described in this study allow for
noninvasive, real-time, spatio-temporal imaging of intra-
cellular tryptophan levels and ﬂux, offering advantages over
conventional analytic methods. The E. coli transcriptional
regulator TrpR was used as the recognition element for the
construction of FRET sensors for tryptophan. As noted
previously, the use of bacterial proteins for the construction
of intracellular sensors reduces the problem of interference
with endogenous metabolic and signal transduction pathways
in eukaryotic cells [41]. Genetically encoded nanosensors
further offer the advantage of subcellular sensor targeting
through judicious choice of leader sequences as demonstra-
ted with nuclear- and ER-targeted glucose nanosensors [42]
and with cell-surface display of glutamate nanosensors [19].
Most FRET nanosensors are based on the ligand-binding–
induced Venus ﬂy trap–like conformational changes of
bacterial PBPs [16–19], which consist of two well-structured
lobes with the ligand-binding site located at the interface.
TrpR is about three times smaller than the average PBP and is
partially unfolded in the absence of tryptophan [25]. In the
presence of tryptophan, the protein adopts the condensed
conformation observed in crystal structures [22], and the
concomitant conformational changes allow for the detection
of tryptophan binding by FRET.
FRET has been a successful reporter signal for small
molecule sensors [43,44]. According to the Fo ¨rster theory, the
efﬁciency of the energy transfer depends on the distance
between the ﬂuorophores and their dipole orientation [45].
These small molecule nanosensors can be engineered by
modiﬁcation of linker sequences between reporter and
sensing domains and/or insertion of ﬂuorophores in surface
loops of the sensing domain, resulting in increased and/or
reversed signal outputs of FRET nanosensors [29]. Because
TrpR dimerizes to form its ligand-binding sites, we applied a
novel approach for engineering of the FRET signal. Insertion
of a second TrpR coding sequence in the principal FLIPW-
CTY sensor changed the FRET response depending on the
position of the insertion site. While insertion before eCFP
and between eCFP and Venus almost eliminated the FRET
response, a TrpR copy after Venus reversed the FRET
response and increased the ratio change. Comparison of
structural models of the FLIPW-CTY and FLIPW-CTYT
sensors predicted that the ﬂuorophores would be closer
together in FLIPW-CTY. Since FRET efﬁciency is inversely
correlated with the distance between the ﬂuorophores as
described in the Fo ¨rster equation [45], the experimentally
determined FRET ratio and the models are consistent.
FLIPW-CTYT was used for monitoring tryptophan uptake
in cell cultures grown in 96-well microtiter plates, making the
sensor suitable for high-throughput assays in which the effect
o fd r u g so rs m a l li n t e r f e r i n gR N A s( s i R N A s )i st e s t e d
systematically [46]. The effective KM for combined trypto-
phan uptake and metabolism in COS-7 cells in microplate
assays and during perfusion was similar with values in the low
micromolar range. We found that a LAT1-like transporter is
responsible for the observed tryptophan exchange in COS-7
cells. Its transport and exchange characteristics are very
similar to that of human LAT1 as expressed in KB cells. The
reported afﬁnity of human LAT1 for tryptophan uptake is 21
lM, about 4-fold lower than determined in this study [35].
However, the values are difﬁcult to compare, because the
former uptake experiments were performed under static
conditions with LAT1 expressed in oocytes and the obtained
afﬁnities relate to the sum of intracellular pools of free,
incorporated, and degraded tryptophan in the large oocytes.
On the other hand, the afﬁnities obtained using FLIPW-
CTYT have been determined for the pool of free tryptophan
in the targeted subcellular compartment, i.e., cytosol, under
perfusion conditions with histidine as a deﬁned counter-
exchange substrate. Possibly, the physiological conditions of
amino acid exchange in the vascular system are mimicked
more accurately by perfusion.
The transporters LAT1 and LAT2 are heteromeric obliga-
tory counterexchangers of large, neutral amino acids with a
1:1 exchange stoichiometry (SLC3 and SLC7) [6,36]. As
exchangers, they do not change the net intracellular amino
acid concentration, but rather modify their relative concen-
trations. Perfusion of FLIPW-CTYT–expressing COS-7 and
KB cells with tryptophan and histidine yielded high-resolu-
tion data of the real-time dynamics of free cytosolic
tryptophan resulting from system L exchange activity.
Importantly, we found that LAT transporters can exchange
kynurenines and tryptophan. Since the individual intra-
cellular and extracellular substrate selectivity of the LAT
transporters are similar [36], kynurenine-tryptophan ex-
change may be bidirectional.
Tryptophan-kynurenine exchange may be part of an
endogenous immunosuppressive mechanism during auto-
immunity and may support the immune escape of prolifer-
ative cell types—like cancer cells—by enhancing the
depletion of the local tryptophan pool and increasing the
serum kynurenine concentrations (Figure 7). Kynurenines
and hydroxy-kynurenine are natural amino acids that are
produced from tryptophan through IDO, whose enzymatic
activity is necessary for immune escape [13]. Macrophages
and dendritic cells express IDO for endogenous suppression
of the immune system [40,47]. Several human cancer cell
lines, including KB cells, up-regulate IDO activity in the
presence of the proinﬂammatory cytokine interferon-c [48].
In addition, IDO can be up-regulated by the mutation of the
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several cancer types [49]. Intracellularly produced kynure-
nines serve as substrates for the exchange for extracellular
tryptophan by LAT transporters, which are expressed in
many tissues and human primary tumors [10]. Effectively,
tryptophan is sequestered from the local environment and
kynurenines accumulate in the serum. The kynurenines
contribute to the pool of amino acids that can be taken up
in exchange for intracellular tryptophan by surrounding cells
expressing LAT transporters, a process which results overall
in a tryptophan ﬂux toward the IDO-producing cells. Since
resting human T cells express only transporters of system L
for the transport of L-tryptophan [50], the tryptophan-
kynurenine exchange mechanism helps to deplete the intra-
cellular tryptophan as well. Both the accumulation of
kynurenines and depletion of tryptophan arrest T cell growth
and induce apoptosis [39,40,51]. Thus, tryptophan-kynure-
nine exchange results in double trouble for T cells (Figure 7).
At the same time, IDO-overproducing cells are protected
from the apoptotic effect of kynurenines by the strict
counterexchange of tryptophan and its stoichiometric deg-
radation products. Cells, e.g., human macrophages, express-
ing transport systems with higher afﬁnities for tryptophan
than LAT1 will be able to continue to proliferate during
ongoing tryptophan sequestration by the combined activity
of LAT1 and IDO [50]. FLIPW sensors can now be used to test
whether T cells take up kynurenines using the same pathway
leading to a further drain of the essential tryptophan. The
sensors can also be used to identify novel drugs and
regulatory factors in genomic RNAi screens or screens of
chemical libraries.
FRET nanosensors are unique tools for studying intra-
cellular, small molecule steady-state levels and ﬂuxes in vivo
and in real time. Ultimately, complete metabolic routes can
be monitored by using nanosensors that selectively detect
single intermediates. For this means, a set of FRET nano-
sensors has been constructed that use the ligand-induced
conformational changes of PBPs [16–19]. As the FLIPW
sensors demonstrate, other protein scaffolds that undergo
conformational changes upon ligand binding can provide
sensing domains for nanosensors with speciﬁcities not
represented in the PBP family, such as tryptophan. E. coli
tryptophan repressor TrpR is not part of a protein family
with different substrate speciﬁcities, which could be used for
the expansion of the current set of nanosensors. However, the
wealth of bacterial transcriptional regulators, which change
afﬁnity for operator sequences upon binding of effectors,
may provide potential sensing domains for novel FRET
metabolite nanosensors.
The FLIPW-CTYT nanosensor has proven to be a robust
system with multiple advantages over conventional methods
for intracellular tryptophan detection. The new sensor thus
provides a complementary tool for monitoring steady state
levels, uptake, and counterexchange, and will be an important
tool for analyzing the factors that control tryptophan ﬂux in
living cells. As the kynurenine/tryptophan exchange demon-
strates, such factors might contribute to important cellular
processes such as inﬂammation and immune escape.
Materials and Methods
Chemicals, strains, plasmids. All chemicals were of analytical grade
and purchased from Sigma-Aldrich (http://www.sigmaaldrich.com). E.
coli strains DH5a, TOP10 F9, and BL21(DE3)gold (Stratagene; http://
www.stratagene.com) were used for transformation of Gateway
reactions, cloning, and protein production, respectively.
Construction of FLIPW sensors. The E. coli trpR gene [52] (EcoGene
EG11029, TrpR: UniProt P0A881) was ampliﬁed from genomic DNA
by PCR for cloning in plasmid pGWF1 through pDONR using
forward primer (59-GGGGACAAGTTTGTACAAAAAAG-
CAGGCTCGGCCCAACAATCACCCTATTCAGC-39) and reverse pri-
mer (59-GGGGACCACTTTGTACAAGAAAGCTGGGTT
ATCGCTTTTCAGCAACACCTCTTC-39) using the Gateway protocol
provided by the manufacturer (Invitrogen; http://www.invitrogen.
com). Plasmid pGWF1 is based on the pRSETb expression vector
(Novagen; http://www.novagen.com) and contains genes for eCFP and
Venus cloned under control of the bacteriophage T7 promoter.
Between the gene sequences of eCFP and Venus, a chloramphenicol
resistance gene and lethal ccdB gene are ﬂanked by attP DNA
sequences for insertion of DNA sequences using Gateway cloning
technology. The trpR gene was sandwiched between the eCFP and
Venus coding sequences resulting in plasmid pTK164. The protein
sequence encoded on pTK164 was denoted FLIPW-CTY. By PCR, trpR
copies ﬂanked with BamHI or HindIII restriction site sequences were
produced. Twin cassette sensor variants were constructed by
insertion of trpR copies into pTK164 using unique BamHI and
HindIII restriction sites respectively before the eCFP coding sequence
(resulting in pTK203) and after the Venus encoding sequence
(resulting in pTK204), resulting in sensor variants encoding the
repressor dimer in a single gene. A construct in which two trpR copies
were connected with a Gly7 linker was denoted pTK205. The gene
products of pTK203, pTK204, and pTK205 were denoted FLIPW-
TCTY, FLIPW-CTYT, and FLIPW-CTTY, respectively. FLIPW con-
structs were harbored in E. coli BL21(DE3)gold, and sensor proteins
were produced and puriﬁed as described previously [17].
In vitro characterization of FLIPW sensors. Puriﬁed sensor was
added to a dilution series of ligand in 20 mM MOPS, pH 7.0, in the
range of 10
 2 to 10
 6 M and analyzed in a monochromator microplate
reader (Saﬁre, Tecan; http://www.tecan.com; eCFP excitation 433/12
nm, eCFP emission 485/12 nm, and Venus emission 528/12 nm). eCFP
shows two emission peaks at 476 nm and 501 nm [53]. The eCFP
emission used for the ratio calculation was determined at 485 nm.
Protein was diluted to give Venus readouts of 20,000–30,000 at a
manual gain of between 70–75. By using the change in FRET ratio
upon binding of ligand, afﬁnity constants (Kd) were determined by
ﬁtting the titration curves to a single-site binding isotherm:
R ¼ Rapo þð Rsat   RapoÞ ð n  ½ L Þ=ðKd þ½ L Þ
Figure 7. Double Trouble for T Cells
Proposed model for the contribution of LAT-mediated tryptophan-
kynurenine exchange to inflammation and immune escape. IDO- and
LAT-expressing cell types such as dendritic cells or cancer cells replace
tryptophan in the local environment with kynurenines. On the one hand,
T cells, expressing LAT transporters for the transport of tryptophan [50],
are drained of tryptophan; on the other hand, kynurenine levels increase.
Both result in T cell growth arrest and apoptosis [39,40,51].
doi:10.1371/journal.pbio.0050257.g007
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ratio; Rapo, ratio in the absence of ligand; and Rsat, ratio at saturation
with ligand. Three independent protein preparations were analyzed
and each protein preparation was analyzed in triplicate.
3D modeling of FLIP TrpR variants. Structural models of FLIPW
sensors were constructed using the crystal structures of Trp repressor
in complex with L-Trp and Venus. Proteins were manually docked in
the various topologies using MAGE (http://rd.plos.org/pbio.0050257).
Tissue culture and transfection. For cytosolic expression in COS-7
and KB cells, the gene encoding CTYT was ampliﬁed by PCR with
primers encoding unique BamHI and EcoRI restriction sites at the 59
and 39 end, respectively, and cloned into BamHI/EcoRI digested
pcDNA3.1(þ) vector (Invitrogen), resulting in plasmid pTK222. COS-7
cells were grown in Dulbecco’s modiﬁed Eagle’s medium (high
glucose; DMEM, Gibco; http://www.invitrogen.com) with 10% fetal
calf serum and 50 units (U)/ml penicillin and 50 lg/ml streptomycin
(Gibco). KB cells were grown in modiﬁed Eagle’s medium alpha
(MEM-a, Gibco) with 10% fetal calf serum and 50 U/ml penicillin and
50 lg/ml streptomycin (Gibco). Cells were cultured at 37 8C and 5%
CO2. For imaging, cells were cultured in 8-well LabTekII German
tissue culture glass slides (Nalge Nunc International; http://www.
nalgenunc.com) and transiently transfected at 50%–70% conﬂuence
using Lipofectamine 2000 Reagent (Invitrogen) in Opti-MEM I
reduced serum medium (Gibco). After transfection, cells were
cultured for 16 h in Opti-MEM I followed by 3 h in growth medium
prior to imaging. Transfection efﬁciency as determined by counting
ﬂuorescing cells was at least 30% for COS-7 and up to 5% for KB.
Microplate assays. Adherent COS-7 cells in 96-well microplates
were washed once with 100 ll Tyrode’s buffer (119 mM NaCl, 2.5 mM
KCl, 2 mM CaCl2, 2 mM MgCl2, 25 mM HEPES, 30 mM glucose, pH
7.3–7.4). The initial FRET ratio was measured by recording the eCFP
and Venus emissions at 485 nm and 528 nm, respectively, after
excitation of eCFP at 433 nm in a Saﬁre monochromator microplate
reader (Tecan). Standard deviation of the initial ratios was less than
10%. After addition of 100 ll tryptophan in Tyrode’s buffer the FRET
ratio was recorded with 2-min intervals for up to 2 h. Uptake rates
were determined from linear parts in the initial FRET change and
ﬁtted with the nonlinear regression program Origin 6.1 (OriginLab;
http://www.originlab.com).
Imaging. Ratio imaging was performed on an inverted ﬂuores-
cence microscope (DM IRE2, Leica; http://www.leica.com) with a
Quant EM digital camera (Photometrics; http://www.photomet.com)
and 203oil immersion, 633water immersion lenses (HC PL APO 203/
0.7 or HCX PL APO, Leica). Dual emission intensity ratios were
simultaneously recorded using a DualView with an OI-5-EM ﬁlter set
(eCFP 480/30; eYFP 535/40; Optical Insights; http://www.
optical-insights.com) and Slidebook 4.2 (Intelligent Imaging Innova-
tions; http://www.intelligent-imaging.com/). A Lambda DG4 (Sutter
Instruments; http://www.sutter.com) provided excitation light. Images
were acquired within the linear detection range of the camera and
exposure times varied between 50 and 200 ms, depending on the
expression level, with software binning between 2 and 3. Fluorescence
intensities for eCFP and Venus were typically in the range of 6,000–
8,000 and 12,000–16,000, respectively. Typical background values
were around 1,000. Cells were perfused with Tyrode’s buffer
supplemented with ligands at ﬂow rates of 1.0 ml/min in a vacuum
chamber (Vacu-Cell VC-MPC-TW, C&L Instruments; http://www.
ﬂuorescence.com/) with a total volume of 0.1 ml. Buffers were
exchanged using an eight-way automated ValveBank (AutoMate;
http://www.autom8.com/). Inhibitors BCH and a-(methylamino)isobu-
tyric acid (MeIAB) were used at 5 mM concentrations. For
determination of the substrate speciﬁcity of tryptophan exchange,
all 20 amino acids were tested at 100 lM concentrations. Analyses
were repeated at least three times with similar results.
Supporting Information
Figure S1. Ligand Speciﬁcity of FLIPW-CTY
Normalized FRET ratio change of FLIPW-CTY in presence of L-
tryptophan (red squares), D-tryptophan (cyan circles), 5-hydroxy-L-
tryptophan (yellow squares), and 5-methyl-L-tryptophan (green
triangles). Ratio is deﬁned as ﬂuorescence intensity quotient of
emission at 528 nm/485 nm.
Found at doi:10.1371/journal.pbio.0050257.sg001 (39 KB DOC).
Figure S2. Relative Position of the Components of the FLIPW-CTYT
Sensor
The TrpR dimer (green, magenta) and Venus (yellow) are modeled to
be sterically compatible, with the termini approaching within 1 A ˚ .
Found at doi:10.1371/journal.pbio.0050257.sg002 (147 KB DOC).
Figure S3. Structural Models of FLIPW-TCTY and FLIPW-CTYT
Tryptophan Sensors
TrpR molecules are shown in green and magenta , eCFP is shown in
blue (based on the Venus structure), and Venus is shown in yellow. (A)
FLIPW-TCTY monomer, (B) FLIPW-CTYT monomer.
Found at doi:10.1371/journal.pbio.0050257.sg003 (496 KB DOC).
Table S1. Signal Change and L-Tryptophan Afﬁnities of FLIPW
Sensors
Found at doi:10.1371/journal.pbio.0050257.st001 (21 KB DOC).
Table S2. Afﬁnities of FLIPW-CTY and FLIPW-CTYT for Tryptophan
Substrates (mM)
Found at doi:10.1371/journal.pbio.0050257.st002 (20 KB DOC).
Accession Numbers
The Protein Data Bank (http://www.pdb.org) accession numbers for
structures discussed in this text are: 1TRO (Trp repressor with
operator), 1MYW (Venus), and 1WRP (Trp repressor in complex with
L-Trp).
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